Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001333079 | SCV001525565 | uncertain significance | Saldino-Mainzer syndrome | 2019-12-13 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Labcorp Genetics |
RCV001333079 | SCV001538947 | likely benign | Saldino-Mainzer syndrome | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002486331 | SCV002784649 | uncertain significance | Saldino-Mainzer syndrome; Retinitis pigmentosa 80 | 2022-05-14 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003888030 | SCV004704971 | uncertain significance | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Ambry Genetics | RCV004987085 | SCV005604228 | likely benign | Inborn genetic diseases | 2024-08-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |